Michael Hamblin


Cofounder OmGeneum, ÉlpisÉremo, ARMADYNE.. widely recognized as the pioneer leading expert of Photobiomodulation. Fmr Associate Professor of Dermatology at Harvard Medical School, Faculty member of Harvard-MIT Health Science and Technology Division. Massachusetts General Hospital Fmr. Principal Investigator at Wellman Center for Photomedicine. He pioneered appli-cations of LLLT transcranial (NIR) light on the healing treatment of traumatic brain injury, stroke, Alzheimer’s dementia,  Parkinson’s neuro-degenerative diseases; depres-sion, anxiety, PTSD, autism, psychiatric disorders. Pioneering research includes: Mechanisms for Photobiomodulation to stimulate healing, prevent tissue death and relieve pain and inflammation